HK1053655A1 - 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs. - Google Patents

4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs.

Info

Publication number
HK1053655A1
HK1053655A1 HK03106016A HK03106016A HK1053655A1 HK 1053655 A1 HK1053655 A1 HK 1053655A1 HK 03106016 A HK03106016 A HK 03106016A HK 03106016 A HK03106016 A HK 03106016A HK 1053655 A1 HK1053655 A1 HK 1053655A1
Authority
HK
Hong Kong
Prior art keywords
mesylat
tetrahydroisoquinol
methanesulfonamido
polymorphs
quinazoline
Prior art date
Application number
HK03106016A
Other languages
English (en)
Inventor
Patricia Ann Basford
Paul Blaise Hodgson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0005200A external-priority patent/GB0005200D0/en
Priority claimed from GB0015900A external-priority patent/GB0015900D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of HK1053655A1 publication Critical patent/HK1053655A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK03106016A 2000-03-03 2003-08-22 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs. HK1053655A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0005200A GB0005200D0 (en) 2000-03-03 2000-03-03 New salt form
GB0015900A GB0015900D0 (en) 2000-06-28 2000-06-28 New salt form
PCT/IB2001/000244 WO2001064672A1 (en) 2000-03-03 2001-02-23 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs

Publications (1)

Publication Number Publication Date
HK1053655A1 true HK1053655A1 (en) 2003-10-31

Family

ID=26243792

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03106016A HK1053655A1 (en) 2000-03-03 2003-08-22 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs.

Country Status (40)

Country Link
US (1) US6683085B2 (pl)
EP (1) EP1268468B1 (pl)
JP (1) JP3857919B2 (pl)
KR (1) KR100496089B1 (pl)
CN (1) CN1214029C (pl)
AP (1) AP2002002611A0 (pl)
AR (1) AR029482A1 (pl)
AT (1) ATE253570T1 (pl)
AU (1) AU779118B2 (pl)
BG (1) BG106869A (pl)
BR (1) BR0108910A (pl)
CA (1) CA2398963C (pl)
CR (1) CR6731A (pl)
CZ (1) CZ20022858A3 (pl)
DE (1) DE60101157T2 (pl)
DK (1) DK1268468T3 (pl)
EA (1) EA004748B1 (pl)
EE (1) EE200200496A (pl)
ES (1) ES2208565T3 (pl)
GE (1) GEP20043364B (pl)
HK (1) HK1053655A1 (pl)
HN (1) HN2001000036A (pl)
HR (1) HRP20020718A2 (pl)
HU (1) HUP0300006A3 (pl)
IL (1) IL150634A0 (pl)
IS (1) IS6441A (pl)
MA (1) MA26876A1 (pl)
MX (1) MXPA02008665A (pl)
NO (1) NO20024195L (pl)
NZ (1) NZ519672A (pl)
OA (1) OA12186A (pl)
PE (1) PE20011225A1 (pl)
PL (1) PL365070A1 (pl)
PT (1) PT1268468E (pl)
SI (1) SI1268468T1 (pl)
SK (1) SK12282002A3 (pl)
TN (1) TNSN01034A1 (pl)
TR (1) TR200302130T4 (pl)
UA (1) UA72311C2 (pl)
WO (1) WO2001064672A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124455D0 (en) * 2001-10-11 2001-12-05 Pfizer Ltd Pharmaceutical formulations
US7163696B2 (en) 2001-10-11 2007-01-16 Pfizer Inc. Pharmaceutical formulations
DE10223913A1 (de) * 2002-05-29 2003-12-11 Bayer Cropscience Ag Verfahren zur Herstellung spezifischer Kristallmodifikationen polymorpher Substanzen
GB0221582D0 (en) * 2002-09-17 2002-10-23 Pfizer Ltd Method of treatment
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
WO2005089804A2 (en) * 2004-03-16 2005-09-29 Pfizer Limited Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists
CN101584696A (zh) * 2008-05-21 2009-11-25 上海艾力斯医药科技有限公司 包含喹唑啉衍生物的组合物及制备方法、用途
CN105596301A (zh) * 2016-01-29 2016-05-25 中国药科大学 一种以异喹啉为基本骨架的p2x7受体拮抗剂的纳米混悬剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914114A (en) 1984-05-28 1990-04-03 Merck Patent Gesellschaft Mit Breschrankter Haftung 3-[4-(4-phenyl-1,2,3,6-tetrahydro-1-pyridyl)butyl]-5-hydroxy-indole methanesulfonate having sedating and anti-parkinsonism properties
EP0281608B1 (de) * 1986-09-16 1990-07-11 MERCK PATENT GmbH Hydroxyindolderivat
GB9700504D0 (en) * 1997-01-11 1997-02-26 Pfizer Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
CZ20022858A3 (cs) 2003-09-17
WO2001064672A1 (en) 2001-09-07
MA26876A1 (fr) 2004-12-20
PE20011225A1 (es) 2001-12-08
EA004748B1 (ru) 2004-08-26
IS6441A (is) 2002-06-25
HN2001000036A (es) 2001-07-09
HRP20020718A2 (en) 2004-02-29
HUP0300006A3 (en) 2006-01-30
US20020010188A1 (en) 2002-01-24
AP2002002611A0 (en) 2002-09-30
CN1214029C (zh) 2005-08-10
BR0108910A (pt) 2002-12-24
CR6731A (es) 2004-03-11
NO20024195D0 (no) 2002-09-03
CN1432010A (zh) 2003-07-23
AU779118B2 (en) 2005-01-06
DE60101157T2 (de) 2004-09-02
UA72311C2 (uk) 2005-02-15
EP1268468A1 (en) 2003-01-02
KR100496089B1 (ko) 2005-06-17
TNSN01034A1 (fr) 2005-11-10
SI1268468T1 (en) 2004-04-30
US6683085B2 (en) 2004-01-27
EP1268468B1 (en) 2003-11-05
ATE253570T1 (de) 2003-11-15
CA2398963C (en) 2006-10-24
PL365070A1 (pl) 2004-12-27
ES2208565T3 (es) 2004-06-16
TR200302130T4 (tr) 2004-01-21
AU3588801A (en) 2001-09-12
DE60101157D1 (de) 2003-12-11
PT1268468E (pt) 2004-01-30
SK12282002A3 (sk) 2003-10-07
NZ519672A (en) 2004-06-25
EE200200496A (et) 2004-02-16
MXPA02008665A (es) 2003-02-24
CA2398963A1 (en) 2001-09-07
JP2003525289A (ja) 2003-08-26
GEP20043364B (en) 2004-03-10
JP3857919B2 (ja) 2006-12-13
AR029482A1 (es) 2003-07-02
EA200200826A1 (ru) 2003-02-27
NO20024195L (no) 2002-09-03
BG106869A (bg) 2002-12-29
IL150634A0 (en) 2003-02-12
OA12186A (en) 2006-05-09
HUP0300006A2 (en) 2003-05-28
DK1268468T3 (da) 2004-02-09
KR20020080463A (ko) 2002-10-23

Similar Documents

Publication Publication Date Title
MXPA03006121A (es) Terapia de combinacion usando inhibidores del receptor tirosin-cinasa e inhibidores de la angiogenesis.
DK1341774T3 (da) Kondenserede heteroaromatiske glucokinase-aktivatorer
ZA200202985B (en) Tyrosine kinase inhibitors.
IL158669A0 (en) Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
HK1061678A1 (en) Pyridazinone aldose reductase inhibitors.
MA26893A1 (fr) Substitution d'aryl sur pyridines, pyrimidines, pyrazines et triazines et utilisation de ces derniers.
ZA200102318B (en) Use of glycogen phosphorylase inhibitors.
DK1480983T3 (da) Heteroarylsubstituerede 2-pyridinyl- og 2-pyrimidinyl- 6,7,8,9-tetrahydropyrimido[1,2a]pyrimidin-4-onderivater
ATE303388T1 (de) Substituierte 2-pyridinyl-6,7,8,9- tetrahydropyrimidoc1,2-aöpyrimidin-4-on- und 7- pyridinyl-2,3-dihydroimidazo-c1,2-aöpyrimidin- 5(1h)onderivate
GC0000151A (en) 2-(3,5-Bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-o-tolyl-pyridin-3-yl)-isobutyramide.
MXPA03004136A (es) Derivados de pirimidina y su uso como ligandos del receptor de neuropeptido y (npy).
HK1053655A1 (en) 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs.
HUP0600064A3 (en) Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl) quinazoline
MXPA03000504A (es) Derivados de pirimidina.
HK1053825A1 (en) Hydrazide and alkoxyamide angiogenesis inhibitors.
HK1062683A1 (en) Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(E)-=-methyloxime and its salts.
ZA200207409B (en) Drilling and anchor setting arrangement.
ZA200304436B (en) Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronatry artery disease or atherosclerosis.
ZA200100906B (en) Uracil compounds and use thereof.
AU2002256260A1 (en) Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
IT249203Y1 (it) Dispositivo a binario e cursore per la realizzazione di elementi decorativi a configurazione variabile, su oggetti personali e/o d'arredo.
HK1061392A1 (en) 5-'4-'2-(N-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione mesylate salt
ZA200104429B (en) Plough and plough share.
ZA982339B (en) 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors.
ITRM20000087U1 (it) Nocciola per caffe'.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090223